You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Former Biden Aide Admits Staff Felt Justified Doing 'Undemocratic Things' to Stop 'Existential Threat' Donald Trump
- 2. Real world prevalence of pelvic lymph node involvement in prostate cancer in Asia: do we need a rethink on normograms?
- 3. Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation
- 4. Biden's presidential health reports showed no sign of recently revealed aggressive cancer
- 5. The epidemiology, etiology, and future prophylactic options for cancers in Mainland China
- 6. Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer
- 7. Tom Robbins, Versatile Muckraker for The Village Voice, Dies at 76
- 8. Brain Cancer Canada Awards $85K to Cutting-Edge Recurrent Glioblastoma Research
- 9. Editorial: Repurposed drugs targeting cancer signaling pathways: clinical insights to improve oncologic therapies, volume II
- 10. Intensity Therapeutics, Inc. to Collaborate with Author, Model, Executive Producer, Speaker and Breast Cancer Survivor Christine Handy to Raise Patient Awareness of Early-Stage Breast Cancer Treatment Options on the Horizon
Last updated at 6:56 GMT
Hot News Makers
Health/Pharma Companies
- 48834.71
- 42444.14
- 34187.95
- 18802.96
- 16196.73
- 14689.99
- 10351.78
- 5985.15
- 4910.89
- 3192.08
Drugs, Treatments, Trials
- 35752.12
- 18244.04
- 6810.24
- 3638.32
- 3355.21
- 2719.46
- 2560.69
- 2506.42
- 2470.70
- 2347.30
Last updated at 6:10 GMT
